ASSENT 3 PLUS(redirected from Assessment of the Safety of a New Thrombolytic-3 Plus)
ASSENT 3 PLUSAssessment of the Safety of a New Thrombolytic-3 Plus. A clinical trial comparing enoxaparin and unfractionated heparin in prehospital management of acute myocardial infarction; ASSENT 3 PLUS failed to meet its primary outcome.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.